Skip to main content
. 2022 Mar 24;10:664261. doi: 10.3389/fcell.2022.664261

FIGURE 1.

FIGURE 1

Human hematopoiesis with characteristic markers, TFs, and miRNAs with potential approaches for HSCs in clinical applications. CLP-common lymphoid progenitor; CMP-common myeloid progenitor; EVs-extracellular vesicles; GMP-granulocyte-macrophage progenitor; HSC-hematopoietic stem cell; LT-HSC-long-term HSC; MEP-megakaryocyte-erythrocyte progenitor; MPP-multipotent progenitor; NK-natural killer; ST-HSC-short-term HSC; TFs-transcription factors.